FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application to allow Pataday Once Daily Relief (olopatadine hydrochloride) for once-daily dosing in allergic conjunctivitis. Thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

SUPPL AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)